Results 31 to 40 of about 14,155 (226)

The management of a cystic hepatic lesion ruptured in the bile ducts: a case report

open access: yesJournal of Medical Case Reports, 2017
Background Hepatic cystadenoma is a rare benign cystic tumor; it tends to recur after incomplete surgical resection and has malignant potential. We report the case of a patient with a ruptured biliary cystadenoma in the common bile duct that caused ...
Hicham Baba   +4 more
doaj   +1 more source

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR‐T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy

open access: yesAdvanced Science, EarlyView.
This study shows that a PARP inhibitor combined with anlotinib, administered as bridging therapy, preconditions the tumor microenvironment to enhance the infiltration and antitumor activity of subsequently infused CAR‐T cells across preclinical ovarian cancer models, supporting bridging therapy as a promising strategy to address limited CAR‐T cell ...
Huayi Li   +20 more
wiley   +1 more source

Application of Serum CA125, HE4, ROMA, and CPH‐I in the Preoperative Differentiation of Ovarian Tumors: A Diagnostic Accuracy Study

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study evaluated the diagnostic performance of CA125, HE4, ROMA, and CPH‐I in 345 patients with histologically confirmed ovarian tumors. CPH‐I showed favorable diagnostic performance overall and was particularly valuable in premenopausal women, whereas ROMA‐based strategies demonstrated optimal performance in postmenopausal women.
Weiming Feng   +6 more
wiley   +1 more source

Case report: Misdiagnosis of primary mucinous cystadenoma of the testicle by ultrasound

open access: yesFrontiers in Oncology, 2023
Testicular mucinous cystadenoma is a rare benign testicular tumor with the characteristics of being potentially malignant and showing atypical clinical symptoms; this article reports a case of a primary testicular mucinous cystadenoma misdiagnosed as ...
Linlin Zhang   +9 more
doaj   +1 more source

Pancreatic cystadenoma and cystadenocarcinoma

open access: yes, 1984
Cystadenomas and cystadenocarcinomas are rare but not exceptional tumours of the pancreas. In this report six cases are added to the more than 300 cystadenomas and over 100 cystadenocarcinomas reported in the literature.
Rohner, A., von Segesser, L.
core   +1 more source

What Are Computer‐Assisted Methods Achieving in Fine‐Needle Aspiration Cytology of the Pancreas? A Systematic Review and Meta‐Analysis

open access: yesCytopathology, EarlyView.
This meta‐analysis demonstrates high diagnostic accuracy of computer‐assisted methods in pancreatic EUS‐FNA cytology (AUC 0.92–0.96) and supports an integrated, cytopathologist‐led workflow in which artificial intelligence functions as an adjunct to diagnostic interpretation and on‐site evaluation (ROSE). Created in BioRender. Mohamed Mirzan, A. (2026)
Al‐Amaan Mohamed Mirzan, Roberto Dina
wiley   +1 more source

MRI Findings in Biliary Cystadenoma

open access: yes, 2014
Biliary cystadenoma is a rare cystic hepatic neoplasm. We herein present a 44 year-old female patient with biliary cystadenoma focusing on difficulties in diagnosis because of lack of specific findings with imaging, and the need for surgery.
Puyan, Fulya Oz   +4 more
core   +2 more sources

3D-modeling Capabilities in Assessing Resectability of Pancreatic Head Tumors

open access: yesВестник рентгенологии и радиологии
Background. Pancreatic head cancer ranks 6–7th among oncologic diseases and 4–5th among causes of mortality, with only 5% of patients achieving 5-year survival rate to date.
A. S. Kudashkina   +4 more
doaj   +1 more source

Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature

open access: yesExploration of Targeted Anti-tumor Therapy, 2023
Neuroendocrine tumours (NETs) are a rare type of tumours that arise from the neuroendocrine cells which are distributed throughout the body. Of all the gastrointestinal tumours only 1–2% account for NETs.
Mangesh Londhe   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy